![Thomas Heineman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Heineman
Technik-/Wissenschafts-/F&E-Leiter bei
ONCOLYTICS BIOTECH INC.
Vermögen: 126 655 $ am 31.07.2026
Profil
Thomas C Heineman is Chief Medical Officer at Oncolytics Biotech, Inc. since 2021.
Former positions include Senior Vice President and Head of Clinical Development at Denovo Biopharma LLC in 2020, Vice President and Head of Clinical Development at Halozyme Therapeutics, Inc. from 2018 to 2020, Vice President and Head of Clinical Development at Genocea Biosciences, Inc. from 2016 to 2020, Senior Director of Clinical Research and Development at GSK Plc from 2006 to 2016, and Associate Professor at Saint Louis University School of Medicine.
Education includes graduate and doctorate degrees from The University of Chicago.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.06.2026 | 168’201 ( 0.14% ) | 126 655 $ | 31.07.2026 |
Aktive Positionen von Thomas Heineman
| Unternehmen | Position | Beginn |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2020 |
Ehemalige bekannte Positionen von Thomas Heineman
| Unternehmen | Position | Ende |
|---|---|---|
Denovo Biopharma LLC
 Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Manufactures personalize and clinical drugs | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2020 |
| GENOCEA BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 |
| HALOZYME THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 |
| GSK PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2016 |
Saint Louis University School of Medicine
 Saint Louis University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ausbildung von Thomas Heineman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
82
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Oncolytics Biotech, Inc.
 Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Saint Louis University School of Medicine
Saint Louis University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Denovo Biopharma LLC
Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Manufactures personalize and clinical drugs | Health Technology |
